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Targeting epigenetic proteins is a rapidly growing area for medicinal chemistry and drug 
discovery. Recent years have seen an explosion of interest in developing small molecules binding to 
bromodomains due to their implication in cancer, inflammation, and a plethora of diseases. Several 
small-molecule inhibitors and degraders that target bromodomains have entered the clinic, and many 
more are increasingly being used as chemical probes to describe bromodomain biology. From a 
structural point of view, crystallographic studies of bromodomains describe, as a common feature, 
five water molecules as an integral part of the acetyl–lysine binding pocket. These water molecules 
are essential in druggability and are described as a functional part of the protein [1,2]. 
In this framework, we focused our attention on the description of the hydrophilic/hydrophobic 
character of these molecules, which seem to create a favorable environment for the recognition of 
hydrophobic groups. To this end, and following fragment-based drug design techniques, here we 
describe a new family of small molecules with a 5-phenylthiazolo[2,3-c][1,2,4]triazol nucleus and 
probe the water site with various substituents at the 3-position endowing hydrophilic or hydrophobic 
properties. In this work, we present the theoretical calculations, the synthesis of the new compounds, 
the results of differential scanning fluorimetry (DSF) and isothermal titration calorimetry (ITC), and 
the crystal structures of three of our compounds with the target protein. The study sheds light on the 
counterintuitive behavior of the water molecules in this particular environment. 
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